Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Emiliano Santarnecchi, Ph.D., Psy.D.

Profile Picture
Other Positions

The Miller Institute , Genova PhDCognitive Behavioral Sciences/Therapy
University of Siena School of MedicinePhDNeurology

Director, Precision Neuroscience & Neuromodulation Program, MGH
Director, Network Control Laboratory, MGH

The research activities and funding listed below are automatically derived from NIH ExPORTER and other sources, which might result in incorrect or missing items. Faculty can login to make corrections and additions.
  1. (Emiliano Santarnecchi) Jul 1, 2020 - Jul 1, 2023
    Gamma Induction for Cognitive Enhancement in Fronto-Temporal Dementia
    Role Description: Double-Blind Randomized Clinical Trial. The project investigates the impact of a six-week tACS intervention in patients with Behavioral Variant Frontotemporal Dementia.
    Role: Principal Investigator
  2. R01AG060981 (SANTARNECCHI, EMILIANO) Feb 1, 2019 - Nov 30, 2023
    Gamma Induction for Amyloid Clearance in Alzheimer?s Disease
    Role: Principal Investigator
  3. HR001117S0030 (Emiliano Santarnecchi) Aug 1, 2018 - Aug 1, 2019
    Effect of Modulating Gamma Oscillations by Transcranial Alternating Current Stimulation on Brain Structure and Function in Humans
    Role Description: The project investigates the feasibility of selectively manipulating brain activity in the gamma range and its corresponding effects on cognition, brain metabolism, anatomy and functional connectivity patterns.
    Role: PI
  4. R01MH115949 (SHAFI, MOUHSIN) Jun 1, 2018 - Feb 28, 2023
    Reliability of Repetitive TMS-induced Modulation of Cortical Excitability
    Role: Co-Investigator
  5. 60182 (Emiliano Santarnecchi) Sep 1, 2017 - Jan 1, 2019
    Chief Academic Officer (CAO) Pilot Grant Award, BIDMC
    Feasibility and Safety of a High-Frequency Transcranial Alternating Current Stimulation Intervention for Amyloid-ß Reduction in Alzheimer’s
    Role Description: This study investigates the safety and feasibility of a novel therapeutic approach for amyloid-beta reduction in patients with Alzheimer’s Disease, assessed using PET imaging before and after transcranial high-frequency electrical stimulation
    Role: PI

Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
This operation might take several minutes to complete. Please do not close your browser.
Local representatives can answer questions about the Profiles website or help with editing a profile or issues with profile data. For assistance with this profile: HMS/HSDM faculty should contact contactcatalyst.harvard.edu. For faculty or fellow appointment updates and changes, please ask your appointing department to contact HMS. For fellow personal and demographic information, contact HMS Human Resources at human_resourceshms.harvard.edu. For faculty personal and demographic information, contact HMS Office for Faculty Affairs at facappthms.harvard.edu.
Santarnecchi's Networks
Click the
buttons for more information and interactive visualizations!
Concepts (288)
Co-Authors (40)
Similar People (60)
Same Department 
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.